Targeting of erbB3 Receptor to Overcome Resistance in Cancer Treatment

Molecular Cancer - United Kingdom
doi 10.1186/1476-4598-13-105
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma

Frontiers in Pharmacology
Pharmacology
2020English

Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2016English

Targeting Efflux Pumps to Overcome Antifungal Drug Resistance

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2016English

Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy

Frontiers in Oncology
Cancer ResearchOncology
2013English

Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non–Small Cell Lung Cancer

Cancer Research
Cancer ResearchOncology
2017English

EP-100 + Paclitaxel to Overcome Taxane Resistance in Patients With Recurrent LHRH-receptor Expressing Ovarian Cancer.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

Drugs Join Forces to Overcome Lung Cancer Resistance

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2009English

Targeting the Warburg Effect With a Novel Glucose Transporter Inhibitor to Overcome Gemcitabine Resistance in Pancreatic Cancer Cells

Carcinogenesis
MedicineCancer Research
2014English

Mechanisms of Acquired Resistance to Androgen Receptor Targeting Drugs in Castration-Resistant Prostate Cancer

Expert Review of Anticancer Therapy
OncologyPharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy